Clinical Trial Update session Saturday June 17

Meet-the-Expert Sessions | Simultaneous Sessions | Clinical Trial Update Session | Science in Progress Session | Hematology-in-Focus Sessions | Lunch Debates | EHA/ASH Joint Symposium | EHA Business Meeting | Plenary Session I | Presidential Symposium - 6 best abstracts | Scientific Working Groups | Poster Session II

CLINICAL TRIAL UPDATE

08.00 - 09.15 hours, Room Y

UPDATE ON AGGRESSIVE LYMPHOMA
Chair: G. Salles (Centre Hospitalier Universitaire, Lyon, France)
  • DLBCL YOUNG PATIENTS WITH FAVORABLE DISEASE (LOCALIZED STAGE AND/OR IPI 0-1)
    J. Schubert (Medical University Saarland, Homburg, Germany)
  • DLBCL YOUNG PATIENTS WITH UNFAVORABLE DISEASE (IPI 2-3)
    D. Caballero (Hospital Universitario de Salamanca, Salamanca, Spain)
  • DLBCL PATIENTS OVER 60-65 YEARS OF AGE
    H. Tilly (Centre Henri Becquerel, Rouen, France)
  • T-CELL LYMPHOMA: A CHALLENGE FOR CLINICAL TRIALS
    F. D'Amore (Ĺrhus Sygehus, Ĺrhus, Denmark)

CLINICAL TRIAL UPDATE

10.30 - 11.45 hours, Room Y

UPDATE ON CLINICAL TRIALS PERFORMED BY MDS COOPERATIVE GROUPS IN EUROPE
Chair: P. Fenaux (Hôpital Avicenne, Paris, France)
  • AN UPDATE FROM THE NORDIC GROUP
    E. Hellström-Lindberg (Karolinska Institutet, Stockholm, Sweden)
  • AN UPDATE FROM THE EORTC GROUP
    P. Muus (Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands)
  • AN UPDATE FROM THE GERMAN GROUP
    A. Ganser (Hannover Medical School, Hannover, Germany)
  • AN UPDATE FROM THE FRENCH MDS GROUP
    P. Fenaux (Hôpital Avicenne, Paris, France)

Top of page ]


EHA Executive Office, Westblaak 71, 3012 KE Rotterdam, The Netherlands | Phone: (+31) 10-4361760 | Email: